Opportunities for Improved Outcomes: The Role of Targeted Therapies in Metastatic Urothelial Carcinoma

Opportunities for Improved Outcomes: The Role of Targeted Therapies in Metastatic Urothelial Carcinoma

Evaluate the latest efficacy and safety data for newer and emerging targeted therapies for mUC. Incorporate current clinical guideline recommendations into clinical practice when caring for patients with mUC. Employ multidisciplinary, patient-centered strategies to select and sequence optimal treatment, manage AEs, and/or address barriers to optimal outcomes in mUC.

  • Provider:HMP Education
  • Activity Link: https://hmpeducation.com/program/24-onccme-107-1
  • Start Date: 2024-12-16 06:00:00
  • End Date: 2024-12-16 06:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: General Surgery
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.